Capsule sponge for early esophageal cancer detection
Part of Cancer, Digestive system clinical trials.
This trial tests a small sponge-on-a-string device (called a capsule sponge) that is swallowed to help detect esophageal cancer early. It may be a gentler way to check the food pipe for cancer than a standard endoscopy, and is being studied in people with esophageal cancer, those at high risk, and healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have either esophageal cancer, a history of head or neck cancer treatment, past treatment for early esophageal cancer, or be a healthy person having an endoscopy for other stomach or digestive symptoms
- Be able to swallow mixed foods and tablets (not just liquids)
- Not be on certain blood-thinning medications that cannot be paused
- Not have had a heart attack or other heart event in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies an “EsophaCap” capsule that can be swallowed during an endoscopy to help detect early esophageal cancer. It may help find cancer earlier and guide next steps, if your results are concerning.
This study checks whether a swallowable capsule can help find signs of Barrett’s esophagus or esophageal cancer (or related risk) before or around an endoscopy. The goal is to see if this less invasive sampling method could improve screening.
This trial tests whether a personalized treatment plan, chosen using a lab-grown model of your tumor, works better than standard therapy for esophageal cancer that can be surgically removed. It aims to find the most effective drugs for you before surgery.
This trial studies how well “liquid biopsy” blood tests can work in people with newly diagnosed, operable esophageal cancer. It may help doctors monitor the cancer and guide treatment planning alongside standard care.
This study checks whether a special sponge you swallow (EsophaCap) can help detect early esophageal cancer—or help sort out concerning symptoms. You may be contacted again 1–2 weeks later for a short interview.
This trial tests if a capsule-sponge device can replace endoscopy for monitoring people with ultralong-segment Barrett's esophagus. It aims to make surveillance easier and less invasive.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.